Aleksandra Rachitskaya, MD, FASRS

home / authors / aleksandra-rachitskaya-md-fasrs

Articles

Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME

Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME

Paul Hahn, MD, PhD, FASRS;Michael Cohen, MD, FAAO;Aleksandra Rachitskaya, MD, FASRS
November 10th 2023

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.

Read More

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Paul Hahn, MD, PhD, FASRS;Michael Cohen, MD, FAAO;Aleksandra Rachitskaya, MD, FASRS
October 31st 2023

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 16th 2024 | Updated: December 22nd 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: November 15th 2024 | Updated: December 22nd 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 22nd 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 22nd 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.